Zealand Pharma A/S (ZEAL) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Zealand Pharma A/S

    NASDAQ: ZEAL · Real-Time Price · USD
    17.59
    0.00 (0.00%)
    At close: Sep 29, 2022, 10:00 PM

    Zealand Pharma A/S Balance Sheet Statement

    Financials in DKK. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q1 2022 Q3 2021 Q4 2021 Q2 2021 Q1 2021
    Period Ending Mar 10, 2022 Sep 30, 2021 Sep 6, 2021 Jun 30, 2021 Mar 31, 2021
    Cash & Equivalents
    		 1.12B 753.6M 1.13B 987.78M 1.31B
    Short-Term Investments
    		 n/a 295.38M 299.04M 295.15M 296.57M
    Long-Term Investments
    		 29.74M 34.68M 26.91M 33.43M 33.9M
    Other Long-Term Assets
    		 29.3M 28.81M 30.36M 29.46M 30.3M
    Receivables
    		 92.58M 118.08M 110.39M 146.56M 81.52M
    Inventory
    		 3.76M 116.36M 118.44M 106.22M 94.81M
    Other Current Assets
    		 362.32M 30.47M 64.63M 39.73M 48.27M
    Total Current Assets
    		 1.58B 1.31B 1.72B 1.58B 1.83B
    Property-Plant & Equipment
    		 187.18M 220.27M 221.45M 225.45M 210.56M
    Goodwill & Intangibles
    		 2.53M 54.71M 53.79M 55.33M 58.02M
    Total Long-Term Assets
    		 255.48M 346.82M 346.03M 348.74M 341.1M
    Total Assets
    		 1.84B 1.66B 2.07B 1.92B 2.17B
    Account Payables
    		 42.42M 54.91M 64.56M 76.22M 46.68M
    Deferred Revenue
    		 54.51M 61.4M 53.03M 72.58M 70.41M
    Short-Term Debt
    		 13.22M 15.53M 14.9M 15.01M 14.45M
    Other Current Liabilities
    		 220.01M 178.86M 201.83M 211.79M 221.4M
    Total Current Liabilities
    		 330.17M 310.7M 334.32M 375.6M 352.93M
    Long-Term Debt
    		 776.98M 126.5M 772.53M 128.77M 114.27M
    Other Long-Term Liabilities
    		 18.43M 37.75M 32.98M 33.07M 39.88M
    Total Long-Term Liabilities
    		 797.52M 164.26M 805.51M 161.84M 154.15M
    Total Liabilities
    		 1.13B 474.95M 1.14B 537.44M 507.08M
    Total Debt
    		 790.2M 142.03M 787.43M 143.77M 128.71M
    Common Stock
    		 43.63M 43.58M 43.63M 43.54M 43.43M
    Retained Earnings
    		 -3.53B -3.03B -3.31B -2.83B -2.53B
    Comprehensive Income
    		 16.18M 12.77M 14.15M 11.08M 11.72M
    Shareholders Equity
    		 709.7M 1.19B 927.8M 1.39B 1.66B
    Total Investments
    		 29.74M 330.06M 325.95M 328.58M 330.46M

    Add to Watchlist